New Ketamine Paper published : Trial protocol for a multicenter randomized controlled trial to assess the efficacy and safety of intravenous ketamine for chronic daily headaches: the “KetHead” trial Yasmine Hoydonckx, Mandeep Singh, Ian Gilron, James Khan, Samer...
Good news for patients suffering from Chronic Migraine or new daily persistent headache. A retrospective review of 77 patients who underwent administration of intravenous, subanesthetic ketamine was conducted by investigators at Thomas Jefferson University....
